These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19551353)

  • 21. Conservative treatment of meibomian gland dysfunction.
    Romero JM; Biser SA; Perry HD; Levinson DH; Doshi SJ; Terraciano A; Donnenfeld ED
    Eye Contact Lens; 2004 Jan; 30(1):14-9. PubMed ID: 14722463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular signs, symptoms and tear function tests of papulopustular rosacea patients receiving azithromycin.
    Bakar O; Demircay Z; Toker E; Cakir S
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):544-9. PubMed ID: 19250326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjögren's syndrome patients.
    Aragona P; Bucolo C; Spinella R; Giuffrida S; Ferreri G
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4474-9. PubMed ID: 16303936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis.
    Akpek EK; Dart JK; Watson S; Christen W; Dursun D; Yoo S; O'Brien TP; Schein OD; Gottsch JD
    Ophthalmology; 2004 Mar; 111(3):476-82. PubMed ID: 15019322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent corneal erosion: clinical features.
    Hope-Ross MW; Chell PB; Kervick GN; McDonnell PJ
    Eye (Lond); 1994; 8 ( Pt 4)():373-7. PubMed ID: 7821454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs.
    Olivero DK; Davidson MG; English RV; Nasisse MP; Jamieson VE; Gerig TM
    J Am Vet Med Assoc; 1991 Oct; 199(8):1039-42. PubMed ID: 1748606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of topical cyclosporine A treatment on corneal thickness in patients with trachomatous dry eye.
    Guzey M; Satici A; Karaman SK; Ordulu F; Sezer S
    Clin Exp Optom; 2009 Jul; 92(4):349-55. PubMed ID: 19473348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of treatment of the dry eye syndrome due to disturbances of the tear film lipid layer with lipid-containing tear substitutes].
    Dausch D; Lee S; Dausch S; Kim JC; Schwert G; Michelson W
    Klin Monbl Augenheilkd; 2006 Dec; 223(12):974-83. PubMed ID: 17199193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial.
    Weissenbacher S; Merkl J; Hildebrandt B; Wollenberg A; Braeutigam M; Ring J; Hofmann H
    Br J Dermatol; 2007 Apr; 156(4):728-32. PubMed ID: 17493072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.
    Wilson SE; Perry HD
    Ophthalmology; 2007 Jan; 114(1):76-9. PubMed ID: 17070588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation and treatment of children with ocular rosacea.
    Donaldson KE; Karp CL; Dunbar MT
    Cornea; 2007 Jan; 26(1):42-6. PubMed ID: 17198012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metronidazole: alternative treatment for ocular and cutaneous rosacea in the pediatric population].
    Léoni S; Mesplié N; Aitali F; Chamaillard M; Boralevi F; Marques da Costa C; Taïeb A; Léauté-Labrèze C; Colin J; Mortemousque B
    J Fr Ophtalmol; 2011 Dec; 34(10):703-10. PubMed ID: 21885154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Double-blind study versus excipient of 0.75% metronidazole gel in the treatment of rosacea].
    Espagne E; Guillaume JC; Archimbaud A; Baspeyras M; Boitier F; Bussière M; Chamberlin J; Coin A; Di Crescenzo MC; Dolivo M
    Ann Dermatol Venereol; 1993; 120(2):129-33. PubMed ID: 8240534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction.
    Perry HD; Doshi-Carnevale S; Donnenfeld ED; Solomon R; Biser SA; Bloom AH
    Cornea; 2006 Feb; 25(2):171-5. PubMed ID: 16371776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline.
    Arman A; Demirseren DD; Takmaz T
    Int J Ophthalmol; 2015; 8(3):544-9. PubMed ID: 26086005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunological phenomenons in the pathology of the tear film. Is cyclosporine the turn point in the Sjögren's syndrome treatment? Preliminary report].
    Kujawa A; Rózycki R
    Klin Oczna; 2004; 106(3 Suppl):489-91. PubMed ID: 15636245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical azithromycin as a novel treatment for ocular rosacea.
    Mantelli F; Di Zazzo A; Sacchetti M; Dianzani C; Lambiase A; Bonini S
    Ocul Immunol Inflamm; 2013 Oct; 21(5):371-7. PubMed ID: 23875944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the effect of cyclosporine-A 0.05% emulsion on the ocular surface and corneal sensation following cataract surgery.
    Hamada S; Moore TC; Moore JE; Al-Dreihi MG; Anbari A; Shah S
    Cont Lens Anterior Eye; 2016 Feb; 39(1):15-9. PubMed ID: 26275686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of ocular surface inflammation in Sjögren syndrome.
    Hyon JY; Lee YJ; Yun PY
    Cornea; 2007 Oct; 26(9 Suppl 1):S13-5. PubMed ID: 17881909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs.
    Morgan RV; Abrams KL
    J Am Vet Med Assoc; 1991 Oct; 199(8):1043-6. PubMed ID: 1748607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.